The top health agency in the UK has issued a warning about a concerning trend of increased flu cases among young children. The UK Health and Security Agency (UKHSA) has observed a rising number of flu cases among schoolchildren nationwide, indicating a potential shift in the flu season timeline. Data from week 42 of 2025 shows a notable increase in flu positivity, with a 6.1 percent rise compared to the previous week. Moreover, the number of hospitalizations due to the virus has also seen a corresponding increase.
According to UKHSA findings, the severity of flu cases has escalated, with hospitalizations climbing from 1.29 to 1.73 per 100,000 individuals within the same week. This surge in cases suggests the likelihood of an earlier onset of the flu season in the country. While the majority of cases are currently affecting schoolchildren, experts caution that the virus could easily spread to other more vulnerable segments of the population.
Dr. Jamie Lopez Bernal, a Consultant Epidemiologist at UKHSA, emphasized the importance of vaccinating children to prevent severe illness in the broader population. Parents are urged to ensure their children receive the nasal spray vaccine offered in schools by returning consent forms promptly. For those who miss the school vaccine, arrangements can be made through local school immunization teams. High-risk children can also obtain the vaccine through their GPs. Dr. Lopez Bernal stressed the significance of other eligible groups getting vaccinated promptly as flu activity continues to circulate in the UK this fall.
The agency’s warning follows concerns raised by UKHSA about the potential severity of this year’s flu season compared to the previous year. Data indicates an increase in GP visits, hospital admissions, and ICU stays for flu-like illnesses in 2025 compared to 2024. The previous season, driven by the H1N1 strain of influenza A followed by influenza B, extended well into March. Vaccination is highlighted as the most effective defense against severe flu-related complications, with eligible groups including individuals over 65, pregnant women, those in clinical risk groups, school-aged children, and two and three-year-olds encouraged to get vaccinated promptly.